Today's News
ELAL 800×100
Peerles 800×100
S&P 600×100
Community Sports 800×100
Shlomo Artzi 800×100

Health

British Columbia to Reimburse AbbVie’s HOLKIRA(TM) PAK

AbbVie’s HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets) will now be reimbursed in British Columbia, Saskatchewan, Manitoba and Yukon. HOLKIRA PAK is an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated cirrhosis. ...

Read More »

A glimmer of hope for patients with leukodystrophies

Leukodystrophies are deadly neurodegenerative diseases that affect one in 7,000 children and remain incurable. These genetic diseases attack myelin or the “insulating rubber sheath” surrounding neurons, which leads to deteriorating health for affected children. Today, nearly 20 types of leukodystrophies have been characterized, but many other forms remain undefined, leaving nearly 40 per cent of families awaiting a diagnosis. An ...

Read More »

Send this to friend